Fed Reaction: Stimulus forever trade, but fiscal policy essential, Oil steady, Gold rally fizzles
Slowing down a ‘helper’ cell may someday make vaccines more effective for seniors
The Ugly Scramble
Russian COVID-19 vaccine approval imminent, source says
Moderna says COVID-19 vaccine pricing to ensure broad access
New survey finds large racial divide in concern over ability to pay for COVID-19 treatment
UK places order for 60m doses of Sanofi/GSK’s COVID-19 vaccine
Macro Briefing | 29 July 2020
Pfizer ups guidance as it prepares to sell off generics division
Pfizer Raises 2020 Profit Forecast On Recovery Outlook; Shares Leap 4%
Consumption data signal trouble ahead for many businesses
MJH Life Sciences Hosts Virology Experts for “COVID-19: Race for a Vaccine” Live Webinar
Texas Deaths Climb As Cases Slide; Moderna Reportedly Prices COVID-19 Vaccine At $60 Per Course: Live Updates
Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates
United Airlines To Cancel Contract With One Of Its Regional Carriers- Report
Japan’s Fujifilm gets $265 million U.S. contract to boost output of potential virus vaccine
After Big Pharma abandoned infectious diseases, 5 biotech contrarians decided to go all in. Then Covid-19 changed everything
New affinity purification technique for therapeutic proteins
This Week’s US Q2 GDP Report Will Be Ugly
Futures Slide As Gold Gets Monkeyhammered After Hitting $2,000
Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate
After down year, 2020 brings new cash into Massachusetts biotech
Brits more comfortable sharing data with pharma since COVID-19 – survey
Trump’s tweets advocate hydroxychloroquine as big COVID-19 vaccine trials start
Macro Briefing | 28 July 2020
Exclusive: Vaccine alliance eyes range of prices for COVID shots
Moderna: Will Negative Patent Ruling Halt COVID-19 Vaccine’s Progress? 5-Star Analyst Weighs In
Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidate
Active management to find yield in fixed income
Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags – sources